公司資料
Deciphera Pharmaceuticals 股價、新聞與催化劑
已下市
- 股票代碼:
- DCPH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for DCPH.
公司概覽
業務概覽
Deciphera Pharmaceuticals is an oncology company that has focused on kinase biology and targeted cancer therapies. The company’s commercial and pipeline efforts are rooted in precision oncology.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Deciphera sits in specialty oncology biotechnology.
商業模式特徵
Its model depends on commercial execution, clinical development, and the ability to extend its targeted-therapy franchise.
生技產業定位
Deciphera is a focused oncology biotech whose valuation is driven by launch performance and pipeline milestones.
未來催化劑
- Deciphera's catalysts are QINLOCK, vimseltinib, and any remaining value-realization update that clarifies what is left to drive the story after the transaction backdrop. The next step matters because the stock is really about how much of the old standalone oncology story still has value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。